Antisense oligonucleotldes made of 2'-OMe RNA are shown to bind specifically and efficiently to targeted sites on pre-mRNA substrates, allowing affinity selection of splicing complexes using streptavidin/blotln chromatography. The position of probe binding to the pre-mRNA influences which type of splicing complex can be selected. The accessibility of pre-mRNA sequences to antisense probes changes during the course of the splicing reaction. U1, U2, U4, U5 and U6 snRNAs are all detected in affinity-selected mammalian splicing complexes. However, antisense oligonucleotides targeted to snRNAs can block the binding of specific snRNPs to pre-mRNA. Quantitative affinity selection analyses show that only a small fraction of snRNPs in a HeLa nuclear splicing extract participate in spliceosome formation.
INTRODUCTION
The accurate splicing of nuclear pre-mRNA can be reproduced in vitro using extracts from both mammalian and yeast cells (1 -3) . Splicing has been shown to occur in a two step pathway, probably involving sequential transesterification reactions (4, 5) . The first step generates reaction intermediates consisting of a free 5' exon and lariat form of the intron joined to the 3' exon. The second step generates spliced exons (i.e. mRNA) and a fully excised intron, still in the form of a lariat. Both these steps take place in a multi-component structure termed a spliceosome (6, 7) . The availability of in vitro splicing systems which can process exogenously added substrates has recently allowed a detailed analysis of the structure of the spliceosome. These studies have shown that the major components of the spliceosome are the U1, U2, U4, U5 and U6 snRNPs (8) (9) (10) (11) . In addition, a number of protein factors, including hnRNP proteins and snRNP accessory factors, have been shown to be present in the spliceosome (12) (13) (14) (15) (16) (17) (18) . Splicing of pre-mRNA is therefore preceeded by splicing complex assembly, which occurs in a highly ordered, stepwise pathway (19) (20) (21) (22) (23) .
We have recently described the synthesis and use of biotinylated 2'-OMe RNA oligonucleotides as antisense probes for studying snRNP particles (24) (25) (26) (27) . 2'-OMe RNA oligonucleotides were shown to form very stable hybrids with complementary RNA sequences. As such hybrids are not substrates for RNase H (28) , snRNP particles bound to biotinylated 2'-OMe RNA probes can be affinity selected by biotin-streptavidin chromatography (26, 27) . These studies have also shown that in certain cases premRNA can be indirectly affinity selected from nuclear extracts when complexed to snRNPs tagged with antisense oigonucleotides. Here we show that a similar affinity selection strategy can be used to study the structure and composition of splicing complexes by targeting antisense oligonucleotides directly to intron or exon sequences on pre-mRNAs. This approach complements and extends the data obtained using anti-snRNP probes and shows that major structural transitions occur in the spliceosome at different stages of the splicing reaction.
MATERIALS AND METHODS Materials
Restriction enzymes were purchased from New England Biolabs (Beverly, MA), RNAsin from Promega (Madison, WI) and RNase H from BRL (Bethesda, MD). Streptavidin agarose beads were purchased from Sigma (St. Louis, MO) and a- 32 P rUTP and Hybond membrane were purchased from Amersham International pic (UK). T3 and T7 RNA polymerases were purchased from Stratagene (La Jolla, CA). HeLa cells used to prepare splicing extracts were purchased from the Computer Cell Culture Centre (Mons, Belgium). Autoradiography film (XAR 5) was purchased from Kodak (Rochester, NY).
Oligonucleotides 2'-OMe RNA oligonucleotides were synthesized on solid phase from base protected 2'-O-methylribonucleoside-3'-O-(2-cyanoethyl N,N-diisopropylphosphoramidites) using 5-(4-nitrophenyl)-lH-tetrazole as activator as described by Sproat et al., (1989) . In each 2'-OMe RNA oligonucleotide Inosine and not Guanosine was used to base pair with Cytosine. Both DNA and 2'-OMe RNA oligonucleotides were synthesized using an Applied Biosystems synthesizer, model 380B-02 (Foster City, California). The sequences of the 2'-OMe RNA oligonucleotides are shown in Table 1 . The biotinylated oligonucleotides have in addition at their termini four 2'-deoxycytidine residues that have
• To whom correspondence should be addressed been modified to carry biotin groups linked via an amino alkyl spacer arm on the exocyclic amino group of the cytidine ring (ref).
In Vitro Splicing Assays HeLa cell nuclear extract was prepared essentially as described by Dignam et al., (1983) but using the modified nuclear extraction conditions described by Barabino et al., (1990) . Adeno premRNA was made from plasmid pBSAdl (Konarska and Sharp, 1987) cut with Sau 3A. Rabbit /3-globin pre-mRNA was made from plasmid pBSAL4 (Lamond et al., 1987) , cut with either Pvu 11 (full length substrate) or Eco R 1 (truncated substrate). All splicing assays were incubated at 30°C for the times indicated in figure legends. Standard reaction conditions are described below in the 'Streptavidin agarose affinity selection assay' section. Transcription of uniformly labelled, capped pre-mRNAs was done as previously described (Lamond et al., 1987) .
Gel Electrophoresis and Northern Hybridization Analyses
RNAs were analyzed by electrophoresis in 10% polyacrylamide (1:30 bis acrylamide:acrylamide)/ 8M urea denaturing gels run in 1XTBE buffer. snRNAs analyzed by northern hybridization were then electroblotted onto Hybond membrane as described by Blencowe et al. (1989) . Hybridization with snRNA-specific riboprobes was done essentially as described by Blencowe et al. (1989) , except that prehybridization was done for 2 hours at 37°C and hybridization was done for 16-20 hours at 37°C. Blots were washed 3 X 200ml 1X SSC (5 minutes per wash at room temperature) followed by 1 x 200ml 0.1 xSSC/0.1% SDS (30 minutes at 65 °C). Both blots and polyacrylamide gels were exposed using a single intensifying screen and Kodak XAR 5 film.
Streptavidin Agarose Affinity Selection Assay
Before use, 100 /tl of streptavidin-agarose beads suspension (Sigma) per 100 /tl reaction volume was pre-blocked to minimize non-specific binding. This was done by addition of tRNA to 100/tg/ml (final concentration) and rotating for 15 minutes at 4°C. Subsequently the beads were pelleted and washed three times with 500 /tl 350mM Washing Buffer (AN^: 20mM Hepes NaOH pH 7.8, 0.01 % Nonidet P40, 35OmM KC1). After the final wash the beads were resuspended in 100/d of WB 35O . pre-mRNA Selection assays were done in 100/tl volume of eidier 'D' buffer (Dignam and Roeder, 1983) or in HeLa nuclear splicing extracts as described below. For snRNA affinity selection experiments 100 /il splicing reactions were used containing: 35% (v/v) HeLa cell nuclear extract (approximately 5 mg/ml final concentration), 2.5mM MgCl 2 , 1.5mM ATP, 5mM creatine-phosphate and 100-150 pMole biotinylated 2'-OMe RNA oligonucleotideyiOO/il reaction volume. The pre-mRNA was used at a final concentration of 1 -2 /tg/ml in the affinity selection experiments. Binding of biotinylated oligonucleotides to pre-blocked streptavidin-agarose beads was done for 45 minutes, rotating at 4°C in a total volume of 600/tl made up with WB 35O . The samples were then spun for 1 minute at 5 k in a microfuge. The pelleted beads were washed twice (10 minutes per wash, rotating in WB35Q at 4°Q and then digested with Proteinase K (1 mg/ml, final concentration) for 45 minutes at 65°C. RNAs were precipitated with 2.5 volumes absolute ethanol using glycogen (20 /ig/ml final concentration) as carrier.
RNase H Assays
RNase H digestion and protection assays were done in 20/tl reaction volumes. For each sample all components were preincubated for 30 minutes at 30°C prior to addition of RNase H. After preincubation, 2 units RNase H per sample was added and incubation continued at 30°C for 45 minutes in a digestion buffer that was; 50mM Tris HC1 pH 7.5, lOmM MgCl 2 , 50mM KC1 and lOmM DTT (final concentrations). RNasin (40 units) and tRNA (20/tg/ml) were also present in each reaction. Oligonucleotides were used at a final concentration of approximately 10 pMoles//tl. Following RNase H cleavage 5/ig tRNA carrier was added and each sample precipitated with ethanol and analyzed on a 5% polyacrylamide/8M urea denaturing gel run in 1 XTBE buffer.
RESULTS

Specificity of oligonucleotide binding to pre-mRNA
The specificity of binding of 2'-OMe RNA oligonucleotides to targeted pre-mRNA sequences was tested using an RNase H protection assay (Fig 1) . This assay exploits the fact that RNA hybridized to DNA, but not to 2'-OMe RNA, is cleaved by RNase H at the site of hybrid formation (28) . Two oligonucleotides, complementary to either exon or intron sequences of an in vitro synthesized /3-globin pre-mRNA, were prepared both as DNA and 2'-0Me RNA (Fig 1A,  oligonucleotides a and b) . Neither of the 2'-OMe RNA oligonucleotides caused RNase H cleavage of the pre-mRNA ( Fig  IB, lanes 3&4 ). In contrast, both DNA oligonucleotides produced specific RNA cleavage in the presence of RNase H (Fig IB, lanes  5&6 ). In the absence of any oligonucleotide RNase H did not cleave the pre-mRNA (Fig IB, lane 2) .
To confirm that the 2'-0Me RNA oligonucleotides can bind sequence-specifically to the pre-mRNA, incubation was initially done with the 2'-0Me RNA b oligonucleotide (cf Fig 1A) , and then RNase H added together with the equivalent DNA b oligonucleotide (Fig IB, lane 7) . In this case no pre-mRNA cleavage occurred. As a positive control for non-specific RNase H inhibition by the 2'-OMe RNA the order of oligonucleotide addition was reversed ( Fig IB, lane 8 ). This shows that the 2'-OMe RNA oligonucleotide did not prevent cleavage when the pre-mRNA was pre-hybridized to the DNA b oligonucleotide. As a positive control for sequence-specificity of RNase H protection by the 2'-OMe RNA oligonucleotide the pre-mRNA was prehybridized with the 2'-OMe RNA b oligonucleotide and then either the DNA c or a oligonucleotides (cf . Fig 1 A ), added together with RNase H (Fig. IB, lanes 9&10 ). In both cases cleavage occurred. We conclude that the 2'-OMe RNA oligonucleotides bind stably and sequence-specifically to complementary target sites on pre-mRNA.
Next, biotinylated 2'-OMe RNA oligonucleotides targeted to sequences in either the intron or exon of a /3-globin pre-mRNA were synthesized and tested for their ability to affinity select premRNA using streptavidin-biotin chromatography (Fig. 2 ). Each probe was tested with both a full-length /3-globin pre-mRNA and a truncated run-off transcript lacking the 3'-terminal binding site for the exon-targeted oligonucleotide (cf. Fig. 2A ). Affinity selection was done using a mixture of the two pre-mRNAs, which can be readily separated by denaturing polyacrylamide gel electrophoresis ( Fig. 2A, lane 3) . As expected, the intron-targeted oligonucleotide (#212) selected both the full-length and truncated pre-mRNAs ( Fig. 2A, lane 4) , while the exon-targeted probe selected only the longer pre-mRNA ( Fig. 2A, lane 5) .
A second experiment compared biotinylated oligonucleotides complementary to the 3' exon of either /3-globin or adeno pre-mRNAs (Fig. 2B) . These pre-mRNAs are unrelated in sequence and can be easily separated by gel electrophoresis (Fig. 2B , lane 1). Neither pre-mRNA is selected by streptavidin agarose chromatography in the absence of an antisense oligonucleotide (Fig. 2B , lane 2), but either the /3-globin (lane 3), or adeno (lane 4), pre-mRNA is specifically selected from a reaction containing an equimolar ratio of both RNAs by the corresponding complementary probe. If both antisense probes are present simultaneously then both pre-mRNAs are selected (lane 5). We conclude that the biotinylated 2'-0Me RNA oligonucleotides can be used for sequence-specific affinity selection of targeted pre-mRNAs.
Affinity selection of in vitro splicing products The specificity of the antisense probes for targeted pre-mRNA sequences was exploited to investigate the association and accessibility of both intron and exon sequences during an in vitro splicing reaction. Biotinylated 2'-OMe RNA oligonucleotides complementary to either intron or 3' exon regions of an adenovirus pre-mRNA were used. As a control for specificity both probes were tested for affinity selection of RNA species purified from an in vitro splicing reaction (Fig. 3C ). All the characteristic RNA intermediates and products of the splicing reaction were present in these samples. No RNA species were selected in the absence of oligonucleotide (Fig. 3C, lane 1) . The intron-targeted probe selected only intron-containing species; i.e. full length pre-mRNA and lariat intermediate and product (Fig.  3C, lane 2) . Similarly, the exon-targeted probe selected only 3' exon-conlaining species; i.e. full length pre-mRNA, spliced exons and 3' exon-intron lariat intermediate (Fig. 3C, lane 3) . Affinity selection was then done in splicing reactions containing HeLa cell nuclear extract (Fig. 3 A&B) . The antisense probes were either preincubated with the adeno pre-mRNA before addition of HeLa nuclear extract (panel A), or added to the reaction after a 120 minute incubation of the pre-mRNA with HeLa extract under splicing conditions (panel B). Interestingly, this revealed a difference in the RNA species that could be affinity selected in each case. When the probes were allowed to bind to the pre-mRNA prior to incubation with nuclear extract (Fig.  3A) , both the intron and exon-targeted oligonucleotides affinity selected the free 5' exon (lanes 2&3). As neither oligonucleotide is complementary to the 5' exon and no selection of this species was observed with the purified RNA splicing products (Fig 3C,  lanes 2&3 ), this result shows that the intermediates of the splicing reaction are held together in the spliceosome during affinity selection. However, a different result is observed for the products of the splicing reaction, i.e. spliced exons and fully excised intron lariat. In this case the 3' exon-targeted probe co-selects both species (panel A, lane 3), consistent with their remaining together in a complex (cf. panel C, lane 3). A similar result is obtained with the /3-globin pre-mRNA using a corresponding, 3' exontargeted oligonucleotide (data not shown). In contrast, the adeno intron-targeted probe predominantly selects the intron lariat but only very low levels of the spliced exons (panel A, lane 2). This observation is discussed below.
A striking difference in the affinity selected RNA species is apparent when the probes are added after the pre-mRNA is incubated under splicing conditions (panel B). In this case both exon and intron-targeted oligonucleotides still affinity select unspliced pre-mRNA; otherwise the intron-targeted probe selects only the intron lariat product (lane 2), while the 3' exon-targeted probe selects only spliced exons (lane 3). Neither probe selects the splicing intermediates. These results are consistent with our previous studies using antisense oligonucleotides targeted against 
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spliceosomal snRNAs (25, 27) . The data shown in figure 3 , panel B, imply that the separate splicing products dissociate after the splicing reaction is completed. However, a post-splicing complex in which the products remain associated may transiently exist and could also be stabilized under certain conditions. Stabilization of a post-splicing complex when an oligonucleotide is bound to the 3' exon (cf. panels A&B, lanes 2&3), could explain the coselection of reaction products by 3' exon-targeted probes. In summary, we conclude that regions exist on the pre-mRNA which are differentially accessible to oligonucleotide binding at different stages of the splicing reaction. This includes regions at which oligonucleotide binding does not prevent subsequent splicing of the pre-mRNA.
Affinity selection of snRNAs in splicing complexes
The selection of splicing intermediates and products by anti-premRNA 2'-OMe RNA oligonucleotides shows that the probes bind to pre-mRNAs assembled into splicing complexes. The presence of snRNAs in affinity-selected complexes was assayed by northern hybridization (Fig. 4 A-C) . snRNAs affinity-selected from a HeLa nuclear splicing extract by a probe targeted to the intron of the adeno pre-mRNA are compared at either time zero (i.e. RNA affinity selected immediately upon mixing of premRNA and nuclear extract), or after a 40 minute incubation under splicing conditions with both pre-mRNA and oligonucleotide present in the reaction (Fig. 4A, lanes 3 & 6) . In agreement with previously reported data (21, 23) , this shows a time-dependent association of the Ul, U2, U4, U5 and U6 snRNAs with the pre-mRNA. At short incubation times we observe a lower fraction of U4, U5 and U6 binding relative to U2 and Ul (data not shown). We note that at least three U5 snRNA variants are able to assemble into splicing complexes. In parallel control experiments no snRNAs were affinity selected if the probe was incubated without pre-mRNA (lanes 2 & 5), or if the pre-mRNA was incubated without oligonucleotide probe (lanes 1 & 4) . These two specificity controls were included in all subsequent affinity selection experiments. The same spliceosomal snRNAs could be affinity selected with both the anti-intron and anti-3' exon adeno probes (Fig. 4B, lanes  3 & 6) . The exon-targeted probe was less efficient at selecting Ul snRNA relative to the other snRNAs. A similar result was observed with a probe targeted to the 3'-exon of the /3-globin pre-mRNA (Fig. 4C) . Again Ul, U2, U4, U5 and U6 snRNAs were affinity selected with the j3-globin pre-mRNA, but with lower levels of Ul relative to the other snRNAs (Fig. 4C, lane  3) . These data are consistent with previous reports showing that Ul is more weakly associated with the spliceosome than the other snRNAs (20, 23) . When a mutant /3-globin pre-mRNA that does not form splicing complexes was analysed no selection of spliceosomal snRNAs was observed (data not shown).
Inhibition of snRNP function prevents snRNP binding to pre-mRNA Both splicing and splicing complex assembly can be inhibited by the binding of antisense 2'-OMe RNA oligonucleotides to specific regions of U snRNAs (25) (26) (27) . We therefore assayed for the binding of snRNAs to pre-mRNA after preincubating HeLa extracts with non-biotinylated oligonucleotides targeted to either U2 or U4 snRNAs (Fig. 5) . As additional negative controls affinity selection was also assayed after each anti-snRNA oligonucleotide was incubated together with the anti-pre-mRNA probe in the absence of exogenously added pre-mRNA (Fig. 5,  lanes 4, 6 and 8) . The non-inhibited, control extract showed again selection of Ul, U2, U4, U5 and U6 snRNAs by the introntargeted anti-adeno pre-mRNA probe (Fig. 5, lane 3) . In contrast, incubation of splicing extracts with antisense oligonucleotides targeted to each of two separate regions of U2 snRNA, or to U4 snRNA, blocked selection of a subset of the spliceosomal snRNAs (Fig. 5, lanes 5, 7 and 9 ). In each case no selection of U4, U5 or U6 snRNAs was observed. This supports our previous findings that these three antisense probes block spliceosome formation (25 -27) . The anti-snRNP oligonucleotides targeted to the 5' terminal sequences of U2 (lane 5) and U4 (lane 9) snRNAs each allow affinity selection of both Ul and U2 snRNAs by the anti-pre-mRNA probe. Both these oligonucleotides also allow formation of pre-splicing complexes when assayed by non-denaturing gel electrophoresis (25, 26 and data not shown). The anti-snRNP probe targeted to the branch site-complementary region of U2 snRNA (lane 7), allows affinity selection of only Ul snRNA by the anti-pre-mRNA oligonucleotide. This anti-U2 probe also blocks pre-splicing complex formation (25, 26) .
The antisense inhibition experiments show that under conditions where it was previously demonstrated by non-denaturing gel electrophoresis assays that a pre-splicing 'A' complex forms, both U2 and Ul snRNAs are detected bound to the pre-mRNA. Ul snRNP can also bind to the pre-mRNA when the binding of U2 snRNP is inhibited and no 'A' complex is detected. Under conditions where binding of U4/U6 snRNP is prevented U5 snRNA is also not affinity selected. This supports models in which U5 enters the spliceosome as part of a U4/U5/U6 triple snRNP particle (22, 29) . Site of Biotinylation
All oligonucleotides are made of 2'-OMe RNA. Biotinylated oligonucleotides each have four tandem bxXin residues linked through additional, non-base pairing deoxycytidines as described by Sproat et al. (1989) . In each case 2'-0Me Inosine was used to base pair with Cytidine residues on the complementary strand. The binding sites for each oligonucleotide were; #211-3' exon of |3-globin premRNA; #212-intron of 0-globin pre-mRNA; # 73-intron of adeno pre-mRNA; #148-3' exon of adeno pre-mRNA; #29-5' terminus of U2 snRNA; #30-branch site complementary region of U2 snRNA; #267-5' terminus of U4 snRNA. Table 1 . Lane 1 corresponds to incubation of adeno prc-mRNA in a control splicing reaction without an antisense oligonucleotide; lane 2 corresponds to the anti-adeno intron oligonucleotide incubated in nuclear extract without pre-mRNA and lane 3 corresponds to a control splicing reaction done with both adeno pre-mRNA and anti-adeno intron oligonucleotide present. Lanes 4, 6 and 8 correspond to control reactions done with both the anti-adeno intron and corresponding antisnRNA oligonucleotides present but without pre-mRNA. Splicing reactions were done for 40 minutes as described in materials and methods. The markers correspond to total HeLa nuclear RNA.
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12 3 12 3 U2 U1 U4 U5 116 Figure 6 . Analysis of the fraction of total snRNA able to bind to pre-mRNA. The level of snRNAs affinity selected using the anti-adeno intron oligonucleotide probe was compared with the level of unselected snRNA remaining in the supernatant fraction. All incubations were for 40 minutes using standard splicing conditions as described in materials and methods. The data shown correspond to the highest efficiency of affinity selection determined empirically by titration of the pre-mRNA concentration. Panels A and B correspond to two exposures of the same blot. Lanes 1 correspond to incubation of adeno pre-mRNA in a control splicing reaction without an antisense oligonucleotide; lanes 2 correspond to the anti-adeno intron oligonucleotide (ref # 73), incubated in nuclear extract without pre-mRNA and lanes 3 correspond to a splicing reaction done with both adeno pre-mRNA and anti-adeno intron oligonucleotide present. The markers correspond to total HeLa nuclear RNA.
The concentration of splkeosomal snRNPs is not limiting for splicing in vitro
The specific affinity selection of spliceosomal snRNAs by premRNA targeted 2'-OMe RNA probes was exploited to address what fraction of the total snRNA in a HeLa nuclear splicing extract could participate in splicing complex formation. The optimum pre-mRNA concentration for splicing complex assembly was therefore titrated to determine the largest quantity of substrate that could be added to the HeLa splicing extract without inhibiting the reaction (data not shown). Affinity selection experiments showed an increase in the level of snRNA isolated in parallel with increasing pre-mRNA concentration up to 3 -4 /ig/ml (data not shown). At higher pre-mRNA concentrations the level of snRNA selection decreased and splicing was inhibited. Figure  6 shows the relative amounts of snRNA in the pellet (i.e. selected) and supernatant (i.e. non-selected) fractions after an affinity selection experiment using the optimal pre-mRNA concentration of approximately 3 /tg/ml. Only a small fraction of the total snRNA is recovered bound to pre-mRNA (cf. lanes 3, pellet and sup.), with a higher level of Ul and U2 snRNAs compared to U4, U5 and U6. Densitometric scanning indicates the maximum level of Ul and U2 affinity selected to be not more than 5 and 12% respectively. For the other snRNAs the maximum level of affinity selection is below 5% of the total amount of each species in the HeLa nuclear extract. This difference most probably reflects the fact that pre-splicing complexes containing only Ul and U2 are co-selected together with fully assembled spliceosomes. The lower molar recovery of Ul as compared to U2 snRNA is likely due to die weaker binding of Ul snRNP to pre-mRNA as previously discussed.
It cannot be excluded diat a sub-fraction of the snRNP particles in the extract are not functional and thus are unable to bind to pre-mRNA. However, in a recent complementary study we have observed that 80-90% of Ul or U2 snRNPs can be depleted from HeLa splicing extracts without reducing the efficiency of splicing (30) . Taken togetfier, these data indicate that the concentration of some factor in the splicing extract other than Ul, U2, U4, U5 or U6 snRNPs is most probably limiting. The results of the snRNP depletion experiments (30) , further argue that the excess snRNP concentration is not required to drive the splicing reaction. This implies that addition of a purified splicing factors) to the HeLa extract could dramatically increase the quantity of pre-mRNA that can be spliced.
DISCUSSION
The specific binding of biotinylated, 2'-0Me RNA oligonucleotides to pre-mRNA has been used to affinity select splicing complexes formed in vitro. This sequence-specific affinity selection system provides a convenient method for analysing the structure and composition of RNP complexes. As helicase activities capable of unwinding RNA duplexes have been reported (31) , it is possible that the use of probes with a mediyl group on the 2' hydroxyl of the ribose inhibits such unwinding enzymes. Using targeted antisense oligonucleotides allows the site of biotin groups on the pre-mRNA to be localized in a way that cannot be done by random incorporation of biotinylated nucleotides into an RNA transcript. As shown in figure 3 , localization of biotin groups at different sites on the pre-mRNA can significandy affect which species of splicing complex can be affinity selected. This flexibility in directing the position of biotin groups on a substrate RNA may prove useful in future studies of other types of RNA/protein complexes.
The presence of Ul snRNP in splicing complexes has been controversial as it has proved difficult to detect Ul in complexes separated by non-denaturing gel electrophoresis or after heparin treatment (20-22, 29, 32) . Ul snRNP has however been reported to be in splicing complexes analysed in two variant gel systems (33, 34) and also in complexes isolated by streptavidinbiotin chromatography in the absence of heparin treatment (23, 35, 36) . Complexes isolated from yeast splicing extracts by a novel affinity selection method that uses antibodies raised against yeast poly (A) binding protein to purify RNAs carrying poly (A) tails have also been shown to contain Ul snRNA (37) . In this study we show that the antisense 2'-OMe RNA affinity selection system detects specific binding of Ul snRNP to pre-mRNAs in mammalian splicing complexes. The data are however consistent with Ul snRNP binding more weakly than the other spliceosomal snRNPs. This weaker binding of Ul snRNP may reflect a difference in the role or mechanism of action of Ul as opposed to the other snRNPs. The data shown in figure 5 indicate that specific binding of Ul snRNP to the pre-mRNA is not prevented by inhibition of U2 or U4 snRNP function. We have also recently shown that Ul snRNP binding to pre-mRNA occurs after quantitative depletion of U2 or U4/U6 snRNPs from HeLa splicing extracts (30) . These data show that recognition of the 5' splice site and binding of Ul snRNP occur wimout obligatory interactions with other snRNP components of the spliceosome. This is consistent with previous studies in yeast where it was shown tfiat at an early stage of spliceosome assembly a 'commitment complex' was formed on the pre-mRNA substrate that contained Ul snRNP but not U2, U5 or U4/U6 snRNPs (34, 38) . This commitment complex may however also contain other non-snRNP components in addition to Ul.
The results presented here extend previous, complementary findings using anti-snRNA probes (25) (26) (27) . In both cases we observe that spliceosomes, once formed, are poorly bound by antisense oligonucleotides targeted to either pre-mRNA or snRNA sequences. However, spliceosomes are subsequendy converted to post-splicing complexes (containing fully excised introns), in which the same targeted sequences are now available for oligonucleotide binding (cf. Fig. 3 ). Thus the products, but not the intermediates, of the splicing reaction can be affinity selected by antisense probes after splicing complex formation has taken place. The fact that the same anti-pre-mRNA probes can select the splicing intermediates when pre-hybridized to pre-mRNA before splicing complex assembly shows that this is not due to inaccessibility of biotin to streptavidin when the probes are bound to spliceosomes. This 'probe-resistant' state of the spliceosome, which appears to occur before the second step of the splicing reaction (but possibly after the first step), may result from steric hindrance due to the transient binding of factors that play a role in structure and/or catalysis. Alternatively, the spliceosome may have evolved a mechanism for excluding interactions widi exogenous nucleic acid sequences in order to prevent abberrant or trans splicing events occurring. Whatever the reason, the data clearly indicate that the spliceosome complex undergoes major changes in structure during the course of the splicing reaction.
